The Medical Letter on Drugs and Therapeutics
FROM
ISSUE938
ISSUE938
December 23, 1994
Cysteamine for Cystinosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Cysteamine for Cystinosis
December 23, 1994 (Issue: 938)
Cysteamine bitartrate (Cystagon - Mylan), an orphan drug, has been approved by the US Food and Drug Administration for oral treatment of nephropathic cystinosis, an autosomal recessive metabolic disorder that affects only a few hundred people in...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.